The National Institutes of Health (NIH), a part of the U.S. Department of Health and Human Services, is the nation’s medical research agency — making important discoveries that improve health and save lives.
The grant aims to support translational activities and small clinical studies focused on the development of low-risk therapeutic and diagnostic devices for disorders affecting the nervous or neuromuscular systems. It encourages applicants to form meaningful collaborations and develop projects that are responsive to this goal. The grant opportunity will open for applications in Spring 2024, with submissions due in Summer 2024, using the R61/R33 activity code.